Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal by Rayamajhi, Ajit et al.
Preparing for rotavirus vaccine introduction – A retrospective
assessment of the epidemiology of intussusception in children below 2
years of age in Nepal
Ajit Rayamajhi a,b,c,⇑, Anupama Thapa a,b, Manoj Kumar d, Catherine Yen e, Jacqueline E. Tate e,
Umesh D. Parashar e, Anjana Karki Rayamajhi a,f
a Janak Medical and Research Center, Balaju, Kathmandu, Nepal
bKanti Children’s Hospital, Maharajgunj, Kathmandu, Nepal
cNational Academy of Medical Sciences, Kathmandu, Nepal
dDepartment of Pediatrics, University of Alberta, Edmonton, Canada
eCenters for Disease Control and Prevention, Atlanta, GA, USA
fB & B Hospital, Gwarko, Lalitpur, Nepal
a r t i c l e i n f o
Article history:
Available online xxxx
Keywords:
Intussusception
Rotavirus vaccine
a b s t r a c t
Background: Rotavirus is the most common cause of severe diarrhea in Nepali children, accounting for
25–33% of childhood diarrhea hospitalizations. Two rotavirus vaccines recommended for inclusion in
national immunization programs have been associated with a low risk of intussusception in post-
marketing studies conducted in several countries. Data on the epidemiology of intussusception hospital-
izations are lacking in Nepal. Thus, we aimed to describe the epidemiology of intussusception-associated
hospitalizations among Nepali children in preparation for rotavirus vaccine introduction.
Methods: A retrospective review of intussusception hospitalizations for a three year period was con-
ducted at two major pediatric hospitals in Kathmandu, Nepal. Possible intussusception cases were iden-
tified through admission, discharge, and operation theater logs and ultrasound registers. Cases with a
diagnosis of possible intussusception were selected for medical record review and classified as confirmed
if they met the Brighton Collaboration level 1 criteria of diagnostic certainty and the child was aged < 24
months. Data on demographics, clinical course, and outcome were abstracted and analyzed.
Results: Eight-five confirmed intussusception cases were identified; most (96%) were confirmed at sur-
gery. The number of intussusception cases peaked between ages 4–7 months; no cases occurred in chil-
dren 0–2 months. Fifty-nine (64%) case-patients were male. The median duration of symptoms before
admission was 2 days (range: 0–14). Abdominal pain, bloody stool, and vomiting were the most common
clinical features. All cases underwent surgical treatment; there was only one death.
Conclusions: This is the first study to evaluate the epidemiology of intussusception hospitalizations
among children aged < 24 months in Nepal. Because the public health impact of rotavirus vaccination
could be substantial in Nepal, where childhood diarrhea-related morbidity and mortality are high, this
baseline knowledge of intussusception prior to introduction of rotavirus vaccine in the national immu-
nization schedule will provide useful information for post-vaccine introduction safety monitoring.
! 2017 Elsevier Ltd. All rights reserved.
1. Introduction
Diarrhea is the second most common cause of death in Nepali
children [1], and rotavirus is the most common cause of severe
diarrhea in these children, accounting for 25–33% of childhood
diarrhea hospitalizations [2,3]. Because of this substantial burden
of disease, the Government of Nepal has included rotavirus vaccine
on its priority list for new vaccines and plans to include rotavirus
vaccine in the national immunization programme in the near
future.
In 1999, a first generation oral rotavirus vaccine, Rotashield
(Wyeth-Lederle), was withdrawn from the US market because of
an increased risk of intussusception, estimated at one excess case
occurring among every 10,000 vaccinated children, primarily in
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the first week after the first vaccine dose [4,5]. The two currently
licensed oral rotavirus vaccines, Rotarix (GlaxoSmithKline Biologi-
cals, Rixensart, Belgium) and RotaTeq (RotaTeq, Merck and Co.,
Whitehouse Station, New Jersey), were assessed for intussuscep-
tion in large pre-licensure clinical trials [6,7]. While no increased
intussusception risk was observed in these trials, post-marketing
studies in several upper middle to high income countries have
detected a small increased risk of intussusception associated with
both vaccines, with an estimated 1–5 excess cases per 100,000 vac-
cinated children [8–13]. Therefore, the World Health Organization
recommends monitoring for intussusception in countries imple-
menting rotavirus vaccines [14].
Intussusception is a rare condition in which the invagination of
one segment of the bowel into another distal segment can result in
obstruction, vascular compromise, necrosis of the intestine, perfo-
ration and even death if untreated. It is the most common cause of
acute bowel obstruction in children below two years of age, with
an estimated mean global incidence of 74 cases (range: 9–328)
per 100,000 children aged < 1 year [15]. However, the incidence
of intussusception varies substantially by geographic region and
limited data on intussusception are available from low income
countries of Asia and Africa. Genetic predisposition, circulating
pathogens, differences in feeding practices and environments,
and differences in access to health care and diagnostic practices
could also contribute to the global differences in intussusception
rates [15].
Data on the epidemiology of intussusception-associated hospi-
talizations are currently lacking in Nepal. Hence, we examined
the immediate clinical outcomes and described the epidemiology
of intussusception-associated hospitalizations among children in
Nepal in preparation for rotavirus vaccine introduction.
2. Methods
We conducted a retrospective review of intussusception hospi-
talizations for a three year period from 1 July 2011 through 30 June
2014 at Kanti Children’s Hospital (KCH), Maharajgunj and Ishan
Children and Women’s Hospital Pvt Ltd (ICWH), Basundhara, two
major pediatric hospitals in Kathmandu, Nepal. These two sites
were selected as they receive the majority of pediatric surgical case
referrals and manage the majority of pediatric intussusception
cases in Nepal. KCH is a public facility providing heavily subsidized
to almost free care to residents of Nepal, while ICWH is a private
facility where patients pay for services.
A member of the research team identified possible intussuscep-
tion cases through review of hospital admission, discharge and
operation theater logs and ultrasound registers. Any case with a
diagnosis of intussusception was selected for medical record
retrieval and case inclusion screening. Children with suspected
intussusception were classified as having a confirmed case of
intussusception if they met the following inclusion criteria: (1) a
ge < 24 months and (2) criteria meeting the Brighton Collaboration
level 1 of diagnostic certainty. Cases met Brighton level 1 diagnos-
tic criteria if they had any of the following findings: (a) invagina-
tion of the intestine at surgery, (b) demonstration of invagination
of the intestine by either air or liquid contrast enema or demon-
stration of an intra-abdominal mass by abdominal ultrasound with
specific characteristic features (target sign or doughnut sign on
transverse section and a pseudokidney or sandwich sign on longi-
tudinal section), that was proven to be reduced by hydrostatic
enema on post-reduction ultrasound, and/or (c) demonstration of
invagination of the intestine at autopsy [16].
Medical records of all children with a confirmed diagnosis of
intussusception were reviewed, and data on demographics, clinical
illness course, and diagnostic, treatment and outcome information
were abstracted using a standardized questionnaire. Descriptive
epidemiological analyses were conducted using SPSS version 16
and SAS version 9.3.
This study was approved by the ethical committee of the Nepal
Health Research Council and Ethical review board of Kanti Chil-
dren’s Hospital.
3. Results
Overall, we identified 106 possible cases of intussusception in
children age < 24 months admitted to KCH and ICWH during the
3-year study period. Of the 106 cases, three (3%) had their specific
age missing and 18 (17%) did not meet the Brighton Collaboration
level 1 diagnostic criteria, so these cases were excluded. A total of
85 cases (74 [87%] from KCH and 11 [13%] from ICWH) were
included in the analysis (Fig. 1); over half (68%) were children from
the Central Development Region of Nepal (Table). Eighty-two cases
(96%) were confirmed at surgery.
Of the 85 confirmed intussusception cases, the number of cases
peaked between the ages of 4 and 7 months (Fig. 2), with a median
age of 7 months (range: 3–23). No cases occurred in children aged
0–2 months, and there was no apparent seasonal pattern in case
occurrence (Fig. 3). Fifty-nine (64%) case-patients were male; the
male: female ratio of cases-patients was 2.3:1 (Table). The median
duration of symptoms before admission was 2 days (range: 0–14).
Abdominal pain (64%), bloody stool (60%), and vomiting (59%)
were the most common clinical features reported. The most com-
mon type of intussusception was ileocolic (72%). All cases under-
went surgical treatment – 73% underwent surgery with simple
manual reduction of the intussusception and were discharged
home without complications, while 27% required intestinal resec-
tion. There was only one death. For 72 cases with available admis-
sion and discharge date, the median length of hospital stay was 6
days.
4. Discussion
This study provides baseline epidemiological information on
naturally occurring intussusception among children aged < 24 mo
nths in Nepal. Important to note is the lack of cases that occurred
during the first 3 months of life and the low mortality rate, despite
the fact that all cases underwent surgical intervention. Our find-
ings are consistent with other reports from the United Kingdom,
Republic of Ireland, Australia, and Malaysia that have described
the peak age of intussusception incidence occurring in the first
year of life, with a very low incidence in the first 2–3 months of life
[17–19]. Also consistent is the male predominance of cases [20–
22]. This male predominance is not completely understood, but
could suggest genetic predisposition to having intussusception
and/or differences in access to health care. Although all intussus-
ception cases underwent surgical intervention, the time between
onset of symptoms and hospital admission was very short, likely
resulting in the good outcomes seen in most cases. The probable
reasons for the preference of surgical intervention are that, in
Nepal, there is greater surgical experience in treating intussuscep-
tion, and hydrostatic reduction is not common. Radiologists are not
trained in hydrostatic intussusception reduction, and the pediatric
surgeons who would be trained in hydrostatic reduction tech-
niques are more experienced with surgical reduction.
This study had several limitations. First, this study may not be
nationally representative of all intussusception cases in Nepali chil
dren < 24 months of age as more than half of the intussusception
cases were from the Central Development Region where the two
hospitals are located. However, the distribution of cases from
almost all the regions of Nepal and our informal survey of referral
patterns for pediatric intussusception for which we found that
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almost all cases are referred to Central Development Region hospi-
tals provide support that our findings could be representative of
the whole country. Second, recruitment of cases depended on ret-
rospective review of the diagnosis of intussusception recorded on
medical charts and other logs. Hence, those without clear docu-
mentation of diagnosis may have been missed. Additionally, some
intussusception cases treated by general surgeons in other hospi-
tals may have been missed. This selection bias could result in an
underestimation of the total number of intussusception cases. Also,
more recent cases may be more likely to be identified than cases
which occurred earlier in the study period due to improved record
keeping and record availability over time. Finally, rotavirus vacci-
nes are available on the private market in Nepal however we were
unable to reliably assess the vaccination status of enrolled cases
due to the retrospective study design.
In conclusion, this is the first study to evaluate the epidemiol-
ogy of intussusception hospitalizations among children aged < 24
months in Nepal. Because the public health impact of rotavirus
vaccination could be substantial in settings like Nepal, where
childhood diarrhea-related morbidity and mortality are high, this
baseline knowledge of intussusception prior to introduction of
rotavirus vaccine in the national immunization schedule will pro-
vide useful information for post-vaccine introduction safety
monitoring.
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103 (97%) intussusception 
cases with age recorded
106 intussusception cases 
<24 months of age
81 (95%) diagnosed by 
surgery
1 (1%) by ultrasound 
and surgery
18 (170%) did not meet 
diagnostic criteria 
3 (3%) missing age
85 (80%) intussusception cases 
enrolled
3 (4%) diagnosed by 
ultrasound*
*Although in general all intussusceptions in both the hospitals were confirmed by ultrasound before 
surgery, records were only available for 3 (4%) patients
Fig. 1. Flow chart of children < 24 months of age admitted to KCH and ICWH with a diagnosis of intussusception ! 1 July 2011 through 30 June 2014.
Fig. 2. Intussusception hospitalizations among children below 2 years of age at KCH and ICWH, by age in months – 1 July 2011 through 30 June 2014 (N = 85).
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